Curis Inc. (NASDAQ:CRIS) up by 5.33%, Aastrom Biosciences Inc (NASDAQ:ASTM)

Posted by Steve Raasch May 14, 2013 0 Comment 1207 views


Curis, Inc. (NASDAQ:CRIS) is by gaining 5.33% in Monday’s trading and closed at $4.35, after starting its day with a value of $4.13. The share ranged in between $4.09 and $4.39 throughout the day. At a price of $4.13 and 1.09 million shares the total value of the company is more than $0.65 million. The earnings per share of the company is -$0.30. The 52-week trading range of the stock is $2.66 and $5.51. At the current levels the stock is trading above the 50 days MA of $3.38 and above its 200 days MA of $3.63. The RSI of the stock is 68.68.

The company announced that Erivedge(R) has received an approval in Australia for marketing registration by the Australia’s Therapeutic Goods Administration. Curis, an oncology-focused company, reported a net loss of $5.0 million, or ($0.06) per share, for the first quarter of 2013, as compared to net income of $2.2 million, or $0.03 per share, for the first quarter of 2012. Revenues for the first quarter were $900,000, as compared to $10.4 million for the same period in 2012.

Aastrom Biosciences Inc (NASDAQ:ASTM) is down by 0.82% in Monday’s trading and closed at $0.595, after starting its day with a value of $0.58. The share ranged in between $0.58 and $0.60 throughout the day. At a price of $0.600 and 45.68 million shares the total value of the company is more than $27.41 million. The earnings per share of the company is -$0.82. The 52-week trading range of the stock is $0.52 and $2.58. At the current levels the stock is trading below the 50 days MA of $0.88 and below its 200 days MA of $1.34. The RSI of the stock is 36.98. Aastrom, a company which develops cell therapies to repair damaged tissues, announced a net loss of $6.8 million, or $0.15 per share, for the first quarter ended March 31, 2013. This compares to a net loss of $9.7 million, or $0.25 per share, for the same period in 2012. As of March 31, the company had a total of $9.2 million in cash and cash equivalents, compared to $13.6 million at December 31, 2012.


About Steve Raasch

Steve Raasch is a breaking news reporter for GDP insider. During his nearly two decades of editorial experience, Steve has covered a variety of topics including small business, health, personal finance, advertising, workplace issues and consumer behavior. Steve is very passionate about his work. Steve earned a master of arts degree in international relations from the Johns Hopkins University School of Advanced International Studies in Washington.

View all post by Steve Raasch Visit author's website

Write Your Comment